Long‐acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies.

Saved in:
Bibliographic Details
Title: Long‐acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies.
Authors: Wulff, Birgitte S.1 (AUTHOR), Chambers, Adam Paul1 (AUTHOR), Osorto Contreras, Cynthia Karenina2 (AUTHOR), Kirkeby, Katrine2 (AUTHOR), Rinnov, Anders Rasmussen2 (AUTHOR), Sustarsic, Riia K.2 (AUTHOR), Østergaard, Søren1 (AUTHOR), Laabs, John E.3 (AUTHOR), O'Neil, Patrick M.4 (AUTHOR) oneilp@musc.edu
Source: Obesity (19307381). Aug2025, Vol. 33 Issue 8, p1457-1474.
Database: SPORTDiscus with Full Text
Description
ISSN:19307381
DOI:10.1002/oby.24329